Novo Biosciences Overview
Update this profile
Novo Biosciences General Information Description
Developer of cardiac drugs designed to reverse the life-threatening damage caused by heart attacks. The company's drugs spur the body to heal itself by triggering powerful mechanisms of self-repair and regrowth that lie dormant in genes, enabling patients to regenerate damaged organs and tissues and live a healthier life.
Novo Biosciences Timeline
Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
Novo Biosciences Valuation & Funding
Raised to Date
6. Seed Round
2. Angel (individual)
To view Novo Biosciences’s complete valuation and funding history, request access »
Novo Biosciences Signals
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial